Abstract
Hormones have a crucial part in the progress and manifestation of a wide variety of different behaviors. The main influence of the neuroendocrine system on behavior is its action on the neurobiology of neuropsychiatric disorders and its relationship with the pharmacodynamics of medicines. Of all the neuroendocrine axes, the hypothalamic-pituitary-adrenal (HPA) axis has been the most extensively studied. There is evidence that disturbance in the HPA axis, the primary stress hormone system, could increase treatment resistance and relapse, worsen illness outcome, and cause cognitive deficits. Glucocorticoids mediate their actions in negative feedback binding in two different cytoplasmatic receptors described as mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs). Different psychopathologies underlying bipolar disorders are supposed to involve persistent dysfunctions in the expression and role of both MR and GR in the hippocampus. We review and analyze the evidence related to the correlation between bipolar disorders and the consequences and impact of stressful life events on the HPA axis, exploring the importance of these findings in bipolar disorders and as potential new targets for treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aas M, Henry C, Andreassen OA, Bellivier F, Melle I, Etain B (2016) The role of childhood trauma in bipolar disorders. Int J Bipolar Dis 4(1):2
Arts B, Jabben N, Krabbendam L, van Os J (2008) Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 38:771–785
Axelson DA, Doraiswamy PM, Boyko OB, Escalona PR, McDonald WM, Ritchie JC, Patterson LJ, Ellinwood J, Nemeroff CB, Krishnan KRR (1992) In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res 44:63–70
Aydin A, Selvi Y, Besiroglu L, Boysan M, Atli A, Ozdemir O, Kilic S, Balaharoglu R (2013) Mood and metabolic consequences of sleep deprivation as a potential endophenotype’ in bipolar disorder. J Affect Disord 150(2):284–294
Born J, Fehm HL (1998) Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system. Exp Clin Endocrinol Diabetes 106(3):153–163
Born J, DeKloet R, Wenz H, Kern W, Fehm HL (1991) Changes in slow wave sleep after glucocorticoids and antimineralocorticoids: a cue for central type I corticosteroid receptors in man. Am J Phys 260:E183–E188
Born J, Steinbach D, Wolff C, Fehm HL (1997) Blocking of central nervous mineralocorticoid receptors (MR) overcomes inhibition of pituitary-adrenal activity in human sleep. J Clin Endocrinol Metab 82:1106–1110
Brown J, Berenson K, Cohen P (2005) Documented and self-reported child abuse and adult pain in a community sample. Clin J Pain 21(5):374–377
Buckley TM, Schatzberg AF (2005) Aging and the role of the HPA axis and rhythm in sleep and memory-consolidation. Am J Geriatr Psychiatry 13(5):344–352
Burdick KE, Goldberg JF, Harrow M (2010) Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up. Acta Psychiatr Scand 122:499–506
Calvo N, Volosin M (2001) Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint. Neuroendocrinology 73(4):261–271
Carpenter LL, Carvalho JP, Tyrka AR, Wier LM, Mello AF, Mello MF et al (2007) Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biol Psychiatry 62(10):1080–1087
Carpenter LL, Tyrka AR, Ross NS, Khoury L, Anderson GM, Price L (2009) Effect of childhood emotional abuse and age on cortisol responsivity in adulthood. Biol Psychiatry 66:69–75
Cassidy F, Murry E, Forest K, Carroll BJ (1998) Signs and symptoms of mania in pure and mixed episodes. J Affect Disord 50:187–201
Cervantes P, Gelber S, Kin FN, Nair VN, Schwartz G (2001) Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci 26(5):411–416
Checkley S (1996) The neuroendocrinology of depression and chronic stress. Br Med Bull 52(3):597–617
Cowen PJ (2002) Cortisol, serotonin and depression: all stressed out? Br J Psychiatry 180:99–100
Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N, Holsboer F, Almeida OF (2005) Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 10:790–798
Daban C, Vieta E, Mackin P, Young AH (2005) Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am 28:469–480
Dallman MF (1984) Viewing the ventromedial hypothalamus from the adrenal gland. Am J Phys 246:R1–R12
Davis AC, Leppanen W, Mularczyk KP, Bedard T, Stroink ML (2018) Systems thinkers express an elevated capacity for the allocentric components of cognitive and affective empathy. Syst Res 35:216–229
de Kloet ER, Reul JM (1987) Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 12:83–105
de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269–301
Deshauer D, Duffy A, Alda M, Grof E, Albuquerque J, Grof P (2003) The cortisol awakening response in bipolar illness: a pilot study. Can J Psychiatr 48:462–466
Dodt C, Kern W, Fehm HL, Born J (1993) Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology 58:570–574
Drevets WC, Price JL, Bardgett ME, Reich T, Todd RD, Raichle ME (2002) Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 71(3):431–447
Duffy A, Lewitzka U, Doucette S, Andreazza A, Grof P (2012) Biological indicators of illness risk in offspring of bipolar parents: targeting the hypothalamic-pituitary-adrenal axis and immune system. Early Interv Psychiatry 6(2):128–137
Ellenbogen MA, Hodgins S, Linnen AM, Ostiguy CS (2011) Elevated daytime cortisol levels: a biomarker of subsequent major affective disorder? J Affect Disord 132:265–269
Eroğlu L, Atamer-Simsek S, Yazici O, Keyer-Uysal M, Yüksel S (1979) A study of the relationship between serum lithium and plasma cortisol levels in manic depressive patients. Br J Clin Pharmacol 8(1):89–90
Etain B et al (2013) Childhood trauma is associated with severe clinical characteristics of bipolar disorders. J Clin Psychiatry 74(10):991–998
Evans DL, Nemeroff CB (1983) The dexamethasone suppression test in mixed bipolar disorder. Am J Psychiatr 140:615–617
Feijo de Mello A, Juruena MF, Pariante CM, Tyrka Audrey R, Price Lawrence H, Carpenter Linda L, Del Porto JA (2007) Depression and stress: is there an endophenotype. Braz J Psychiatr 29:13–18
Flory JD, Yehuda R, Grossman R, New AS, Mitropoulou V, Siever LJ (2009) Childhood trauma and basal cortisol in people with personality disorders. Compr Psychiatry 50(1):34–37
Gallagher P, Gray JM, Watson S, Young AH, Ferrier IN (2014) Neurocognitive functioning in bipolar depression: a component structure analysis. Psychol Med 44:961–974
Gallagher P, Nilsson J, Finkelmeyer AE, Goshawk M, Macritchie KA, Lloyd AJ, Thompson JM, Porter RJ, Young AH, Ferrier IN, McAllister-Williams RH, Watson S (2015) Neurocognitive intra-individual variability in mood disorders: effects on attentional response time distributions. Psychol Med 45:2985–2997
Geddes JR, Miklowitz DJ (2013) Treatment of bipolar disorder. Lancet 381(9878):1672–1682
Gold PW, Chrousos GP (2002) Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 7(3):254–275
Grottoli S, Giordano R, Maccagno B, Pellegrino M, Ghigo E, Arvat E (2002) The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans. J Clin Endocrinol Metab 87:4616–4620
Haussleiter IS, Neumann E, Lorek S et al (2020) Role of child maltreatment and gender for bipolar symptoms in young adults. Int J Bipolar Dis 8:10
Havermans R, Nicolson NA, Berkhof J, de Vries MW (2011) Patterns of salivary cortisol secretion and responses to daily events in patients with remitted bipolar disorder. Psychoneuroendocrinology 36(2):258–265
Heim C, Nemeroff CB (1999) The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol Psychiat 46:1509–1522
Holsboer F, Barden N (1996) Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 17:187–205
Juruena MF (2014) Early-life stress and HPA axis trigger recurrent adulthood depression. Epilepsy Behav 38:148–159
Juruena MF, Cleare AJ (2007) Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome. Braz J Psychiatr 29:20–27
Juruena MF, Cleare AJ, Bauer ME, Pariante CM (2003) Molecular mechanism of GR sensitivity and relevance for affective disorders. Acta Neuropsychiatr 15:354–367
Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM (2006) Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology 189:225–235
Juruena MF, Marques AH, Feijó de Mello A, Feijó de Mello M (2007) A paradigm for understanding and treating psychiatric illness. Braz J Psychiatr 29:1–2
Juruena MF, Pariante CM, Papadopoulos AS, Poon L, Lightman S, Cleare AJ (2009) Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. Br J Psychiatry 194:342–349
Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM (2010) The prednisolone suppression test in depression: dose response and changes with antidepressant treatment. Psychoneuroendocrinology 35:1486–1491
Juruena MF, Calil HM, Fleck MP, Del Porto JA (2011) Melancholia in Latin American studies: a distinct mood disorder for the ICD-11. Braz J Psychiatr 33:S48–S58
Juruena MF, Pariante CM, Papadopoulos AS, Poon L, Lightman S, Cleare AJ (2013) The role of mineralocorticoid receptor function in treatment-resistant depression. J Psychopharmacol 27(12):1169–1179
Juruena MF, Baes CVW, Menezes IC, Graeff FG (2015) Depressive patients: role of glucocorticoid and mineralocorticoid receptors and of hypothalamic-pituitary-adrenal axis activity. Curr Pharm Des 21(11):1369–1378
Juruena MF, Agustini B, Cleare AJ, Young AH (2017) A translational approach to clinical practice via stress-responsive glucocorticoid receptor signalling. Stem Cell Invest 16(4):13
Juruena MF, Bocharova M, Agustini B, Young AH (2018) Atypical and non-atypical depression: is HPA axis function a biomarker? J Affect Disord 233:45–67
Kagan J, Reznick JS, Snidman N (1987) The physiology and psychology of behavioral inhibition in children. Child Dev 58(6):1459–1473
Kamali M, Saunders EF, Prossin AR, Brucksch CB, Harrington GJ, Langenecker SA et al (2012) Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder. J Affect Disord 136:350–358
Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, MurphyJr GM, Schatzberg AF (2017) HPA axis in major depression: cortisol, clinical symptomatology, and genetic variation predict cognition. Mol Psychiatr 22(4):527–536
Kendler KS, Hettema JM, Butera F, Gardner CO, Prescott CA (2003) Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch Gen Psychiatry 60(8):789–796
Kuningas M, de Rijk RH, Westendorp RG, Jolles J, Eline Slagboom P, van Heemst D (2007) Mental performance in old age dependent on cortisol and genetic variance in the mineralocorticoid and glucocorticoid receptors. Neuropsychopharmacology 32:1295–1301
Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Plotsky PM (2004) Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation. Biol Psychiatry 55:367–375
Linkowski P, Kerkhofs M, van Onderbergen A, Hubain P, Copinschi G, L’hermite-Baleriaux M et al (1994) The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania. Arch General Psychiatr 51:616–624
Lopez JF, Chalmers DT, Little KY, Watson SJ, A.E. Bennett Research Award (1998) Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43:547–573
Manenschijn L, Spijker AT, Koper JW, Jetten AM, Giltay EJ, Haffmans J et al (2012) Long-term cortisol in bipolar disorder: associations with age of onset and psychiatric co-morbidity. Psychoneuroendocrinology 37(12):1960–1968
Martins-Monteverde CMS, Baes CVW, Reisdorfer E, Padovan T, Tofoli SMC, Juruena MF (2019) Relationship between depression and subtypes of early life stress in adult psychiatric patients. Front Psychiatry 10:19
Mason BL, Pariante CM (2006) The effects of antidepressants on the hypothalamic-pituitary-adrenal axis. Drug News Perspect 19(10):603–608
Mazer AK, Cleare AJ, Young AH, Juruena MF (2019) Bipolar affective disorder and borderline personality disorder: differentiation based on the history of early life stress and psychoneuroendocrine measures. Behav Brain Res 357:48–56
McAllister-Williams RH, Man MS, Young AH (1999) Effects of adrenalectomy on 8-OH-DPAT induced hypothermia in mice. Psychopharmacology 142:73–77
McAllister-Williams RH, Anderson AJ, Young AH (2001) Corticosterone selectively attenuates 8-OH-DPAT-mediated hypothermia in mice. Int J Neuropsychopharmacol 4:1–8
McEwen BS (2001) From molecules to mind. Stress, individual differences, and the social environment. Ann N Y Acad Sci 935:42–49
McEwen BS (2004) Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci 1032:1–7
McQuade R, Young AH (2000) Future therapeutic targets in mood disorders: the glucocorticoid receptor. Br J Psychiatry 177:390–395
Murray G, Harvey A (2010) Circadian rhythms and sleep in bipolar disorder. Bipolar Disord 12(5):459–472
Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor like immunoreactivity in depressed patients. Science 226:1342–1344
Pace TW, Spencer RL (2005) Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor. Am J Physiol Endocrinol Metab 288:E1082–E1088
Palma BD, Tiba P, Machado RB, Tufik S, Suchecki D (2007) Immune outcomes of sleep disorders: the hypothalamic-pituitary-adrenal axis as a modulatory factor. Braz J Psychiatr 29(Suppl 1):s33–s38
Porter RJ, Gallagher P, Watson S, Young AH (2004) Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology 173:1–17
Post RM (2007) Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev 31(6):858–873
Post RM (2010) Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res 18:256–271
Raison CL, Miller AH (2003) When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 160(9):1554–1565
Ratka A, Sutanto W, BLoemers M, de Kloet ER (1989) On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50:117–123
Ray O (2004) The revolutionary health science of psychoendoneuroimmunology: a new paradigm for under- standing health and treating illness. Ann N Y Acad Sci 1032:35–51
Reul JM, Gesing A, Droste S, Stec IS, Weber A, Bachmann C, Bilang-Bleuel A, Holsboer F, Linthorst AC (2000) The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur J Pharmacol 405:235–249
Rijsdijk FV, Sham PC, Sterne A, Purcell S, McGuffin P, Farmer A, Goldberg D, Mann A, Cherny SS, Webster M, Ball D, Eley TC, Plomin R (2001) Life events and depression in a community sample of siblings. Psychol Med 31(3):401–410
Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN et al (2006) A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 93:105–115
Rosenblat JD, McIntyre RS (2017) Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci 7(11)
Sapolsky RM, Romero M, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21(1):55–89
Schatzberg AF, Rothschild AJ, Stahl JB, Bond TC, Rosenbaum AH, Lofgren SB, MacLaughlin RA, Sullivan MA, Cole JO (1983) The dexamethasone suppression test: identification of subtypes of depression. Am J Psychiatry 140(1):88–91
Schatzberg AF, Keller J, Tennakoon L, Lembke A, Williams G, Kraemer FB, Sarginson JE, Lazzeroni LC, Murphy GM Jr (2014) HPA axis genetic variation, cortisol, and psychosis in major depression. Mol Psychiatr 19(2):220–227
Schlesser MA, Winokur G, Sherman BM (1980) Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification. Arch General Psychiatr 37:737–743
Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJE (1995) Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol Psychiatry 38:797–802
Sher L, Cooper TB, Mann JJ, Oquendo MA (2006) Modified dexamethasone suppression-corticotropin-releasing hormone stimulation test: a pilot study of young healthy volunteers and implications for alcoholism research in adolescents and young adults. Int J Adolesc Med Health 18(1):133–137
Smythe JW, Murphy D, Timothy C, Costall B (1997) Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharmacol Biochem Behav 56(3):507–513
Spencer RL, Kim PJ, Kalman BA, Cole MA (1998) Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 139:2718–2726
Steiger A, Rupprecht R, Spengler D, Guldner J, Hemmeter U, Rothe B, Damm K, Holsboer F (1993) Functional properties of deoxycorticosterone and spironolactone: molecular characterization and effects on sleep endocrine activity. J Psychiatr Res 27:275–284
Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N et al (1992) Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand 85:270–274
Tatro ET, Everall IP, Kaul M, Achim CL (2009) Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res 1286:1–12
Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN et al (2005) Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 186:32–40
Valiengo LL, Soeiro-de-Souza MG, Andreazza AC, Juruena MF, Gattaz WF, Moreno DH, Marques AH, Machado-Vieira R (2012) Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood. J Affect Disord 138:149–152
Varghese P, Brown S (2001) The hypothalamic-pituitary adrenal Axis in major depressive disorder: a brief primer for primary care physicians Femina. Curr Gene Ther
Venkatasubramanian G, Chittiprol S, Neelakantachar N, Shetty T, Gangadhar BN (2010) Effect of antipsychotic treatment on insulin-like growth Factor-1 and cortisol in schizophrenia: a longitudinal study. Schizophr Res 119:131–137
Vieta E, Gasto C, Martinez de Osaba MJ et al (1997) Prediction of depressive relapse in remitted bipolar patients using corticotrophin-releasing hormone challenge test. Acta Psychiatr Scand 95(3):205–211
Vieta E, Martínez-De-Osaba MJ, Colom F, Martínez-Arán A, Benabarre A, Gastó C (1999) Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients. Psychol Med
Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH (2004) Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 184:96–502
Watson S, Thompson JM, Ritchie JC, Nicol Ferrier I, Young AH (2006) Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function. Bipolar Disord 8:85–90
Watson S, Bruce M, Owen BM, Gallagher P, Hearn AJ, Young AH et al (2007) Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: mediation of the vulnerability to mood disorders. Neuropsychiatr Dis Treat 3(5):647–653
Wiedemann K, Lauer C, Pollmächer T, Holsboer F (1994) Sleep endocrine effects of antigluco- and antimineralocorticoids in healthy males. Am J Phys 267:E109–E114
Wingenfeld K (2010) HPA axis and neuroimaging in BPD. Psychoneuroendocrinology 35:154–170
Yohn CN, Gergues MM, Samuels BA (2017) The role of 5-HT receptors in depression. Mol Brain 10(1):28
Young AH, Juruena MF (2018) Hypothalamic-pituitary-adrenal (HPA) axis. In: Ismail K, Barthel A, Bornstein SR, Licinio J (eds) Depression and type 2 diabetes, pp 59–72
Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H (1998) The role of mineralocorticoid receptors in hypothalamic-pituitary- adrenal axis regulation in humans. J Clin Endocrinol Metab 83:3339–3345
Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H (2003) Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 60:24–28
Young EA, Altemus M, Lopez JF, Kocsis JH, Schatzberg AF, DeBattista C et al (2004) HPA axis activation in major depression and response to fluoxetine: a pilot study. Psychoneuroendocrinology 29:1198–1204
Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M (2001) Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study. J Psychiatr Res 35(2):83–94
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Juruena, M.F., Cleare, A.J., Young, A.H. (2020). Neuroendocrine Stress System in Bipolar Disorder. In: Young, A.H., Juruena, M.F. (eds) Bipolar Disorder: From Neuroscience to Treatment. Current Topics in Behavioral Neurosciences, vol 48. Springer, Cham. https://doi.org/10.1007/7854_2020_184
Download citation
DOI: https://doi.org/10.1007/7854_2020_184
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-72142-8
Online ISBN: 978-3-030-72143-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)